Position in ABBV
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$289,386
+$101,475 QoQ
Shares Held
1,150
+33.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3,660
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arlington Trust Co LLC holds $1,296,049 across 14 Drug Manufacturers - General names. ABBV ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
278 | $333,441 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,150 | $289,386 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,750 | $224,875 | |
| 4 | JNJ |
Johnson & Johnson
|
771 | $195,810 | |
| 5 | AMGN |
Amgen Inc
|
254 | $91,978 | |
| 6 | NVS |
Novartis AG
|
288 | $45,135 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
610 | $35,148 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
212 | $26,784 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $289,386 | 1,150 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $187,911 | 864 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $121,099 | 530 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,338,069 | 5,779 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,072,697 | 5,779 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,252,091 | 5,976 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,204,450 | 6,778 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,318,771 | 6,678 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,138,549 | 6,638 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $919,605 | 5,050 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $805,844 | 5,200 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||